Patients

More treatment options mean more flexibility for people with cancer

Additional treatment options can help patients make time for their health and their priorities

October 28, 2025

Share this article

Facebook icon

.st0{fill:#00857C;} X icon

Linkedin icon

Email icon

young woman standing in the kitchen with her arm around an older woman and a man standing and smiling

Every person diagnosed with cancer is unique. That’s why it’s so important for patients to have more treatment options, including ones that for some patients could be given in different care settings that are closer to home. This may give them flexibility and potentially allows them to have more time to care for their health.

Understand cancer treatment options

Advances in cancer treatment are happening every day and therapeutic options are continuously expanding. The right cancer treatment for a given patient depends on many factors including the type of cancer they have, the stage of their cancer and their overall health. Some common options include:

  • Radiation therapy
  • Chemotherapy
  • Hormone therapy
  • Targeted therapy
  • Immunotherapy
  • Surgery

Each of these types of cancer treatment work in a unique way to help treat the disease. Certain treatments also can be delivered in different ways, including but not limited to:

  • Orally: Via a pill or something taken by mouth
  • Topically: Applied to the surface of the skin
  • Intravenously: Administered through a needle or tube inserted into a vein (also called an infusion, when the medication is delivered over a specified period of time)
  • Subcutaneous injection: Via a needle inserted directly into the fatty tissue layer between the skin and muscle — or right under your skin

As additional treatment options become available, patients and caregivers are more likely to be able to consider which treatment option works best for their condition, lifestyle and preferences.

Researchers are exploring how to make treatment more flexible

Traditionally, some therapies have been administered only in hospitals and infusion clinics, often requiring patients to travel for their care, which can be time-consuming and burdensome. Once patients arrive, there are multiple steps health care providers must take in preparing for and administering treatment and observing the patient afterwards. A treatment day can be long when you consider the time from when patients leave their homes to the time they return from treatment.

Recent research has led to options that may allow for treatment to be administered subcutaneously rather than intravenously, making it possible for patients to receive treatment in more health care settings such as a doctor’s office or a community-based care center. With more choices available, patients have options that may allow them to personalize their treatment approach based on their specific lifestyle needs, so they can focus on other things that matter to them. These options may also provide additional flexibility and time savings for health care providers and systems.

“Time is one of the most valuable resources we all have, and at MSD we believe in prioritizing health so we can embrace every moment.”

  • Dr. M. Catherine Pietanza
    Vice president of global clinical development, MSD

“Cancer is not a one-size-fits-all disease, so it’s important that health care providers are able to offer treatment options that allow patients more flexibility,” said Pietanza.

Make time for your health — and the other parts of your life, too

Roz Faulhaber, a school counselor who had colorectal cancer, discovered firsthand the challenges of finding enough hours in the day to make time for everything following a cancer diagnosis.

“Receiving cancer treatment while trying to maintain a sense of normalcy in my life has been very challenging at times. I commute several hours to my treatment center and once I get there, the treatment itself can take hours. I want to spend more of my day with my grandchildren or relaxing at our beach home,” said Faulhaber.

“Discussing my treatment options with my doctor has been crucial — they’ve helped me select a care plan that best meets my needs, and we continue to discuss options that could give me time back in my day and flexibility.”

  • Roz Faulhaber

Patients should talk to their health care provider about treatment options, including methods of administration and dosing schedules, that fit their needs and may provide them with more flexibility

Learn about our oncology research.

Patients

Podcast: A candid conversation about diversity in clinical trials 

Hear a patient and a doctor share why they want more people involved in medical studies

May 2, 2024

Share this article

Facebook icon

.st0{fill:#00857C;} X icon

Linkedin icon

Email icon

Header image for diversity in clinical trials story

Clinical trials are an important part of helping to ensure new medicines are safe and effective. Yet a lack of awareness and feelings of hesitancy about joining one persist. 

Some people are uncertain about medical research due to past studies like the Tuskegee Experiment, when Black men were denied treatment for syphilis in the 1930s. Today, many are cautious when receiving advice from members of the medical community, including their doctors.  

Euvon Jones — a motivational artist, proud father and husband and a former clinical trial participant — hadn’t thought much about clinical trials before his diagnosis with prostate cancer, but he eventually decided to participate in a study to advance knowledge of the condition not only for himself but also for his community.

Listen to the podcast

Read the transcript

In this podcast, Jones joined Adrelia Allen, executive director of clinical trial patient diversity at our company, and Dr. Renee Matthews, director of live programming and production at BlackDoctor.org, to share the factors that impacted his decision to participate in a clinical trial and how that experience changed his perspective on medical research.

Jones said it’s hard to trust the process if you don’t trust your health care provider or the person recommending a clinical trial. “Good information might be provided, but you have to trust that the information is good for you,” he said. 

Additionally, Matthews discussed how misinformation perpetuates stigma around clinical trials and the work that her organization is doing to help instill confidence in people who are considering participating in clinical trials.  

Learn more about how we’re prioritizing diversity in clinical trials and why it’s so important.

Patients

Podcast: How to bridge diversity gaps in cancer clinical trials

Luther Clark talks with Lazarex Cancer Foundation's Dana Dornsife and Marya Shegog about increasing access among historically underrepresented communities

May 17, 2021

Share this article

Facebook icon

.st0{fill:#00857C;} X icon

Linkedin icon

Email icon

Podcast graphic of Dr. Luther Clark, Dr. Marya Shegog and Dana Dornsife

Diversity in cancer clinical trials is essential to show if potential treatments are safe and work well for people of all different communities. That’s why it’s crucial to break down barriers and increase participation in cancer clinical trials among historically underrepresented communities.

In this podcast, Luther Clark, MSD’s deputy chief patient officer, speaks with the Lazarex Cancer Foundation’s founder and CEO, Dana Dornsife, and its health equity and diversity coordinator, Marya Shegog, about the work they’ve been doing — and the work that still needs to be done — to foster health equity through cancer clinical trials.

Listen to the podcast

Read the transcript